Oregon Public Employees Retirement Fund Acquires 2,793 Shares of STERIS plc $STE

Oregon Public Employees Retirement Fund raised its holdings in STERIS plc (NYSE:STE) by 33.0% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 11,252 shares of the medical equipment provider’s stock after acquiring an additional 2,793 shares during the quarter. Oregon Public Employees Retirement Fund’s holdings in STERIS were worth $2,784,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of STE. Mediolanum International Funds Ltd raised its stake in shares of STERIS by 9.0% during the 2nd quarter. Mediolanum International Funds Ltd now owns 62,327 shares of the medical equipment provider’s stock worth $14,883,000 after acquiring an additional 5,156 shares in the last quarter. Entropy Technologies LP increased its holdings in shares of STERIS by 282.2% during the second quarter. Entropy Technologies LP now owns 9,099 shares of the medical equipment provider’s stock valued at $2,186,000 after acquiring an additional 6,718 shares in the last quarter. Vanguard Group Inc. raised its position in shares of STERIS by 1.7% in the 2nd quarter. Vanguard Group Inc. now owns 12,163,128 shares of the medical equipment provider’s stock valued at $2,921,827,000 after purchasing an additional 205,276 shares during the last quarter. Asset Management One Co. Ltd. boosted its stake in STERIS by 5.4% in the 3rd quarter. Asset Management One Co. Ltd. now owns 98,487 shares of the medical equipment provider’s stock worth $24,366,000 after purchasing an additional 5,072 shares in the last quarter. Finally, KLP Kapitalforvaltning AS grew its position in STERIS by 5.3% during the 2nd quarter. KLP Kapitalforvaltning AS now owns 33,800 shares of the medical equipment provider’s stock worth $8,119,000 after purchasing an additional 1,700 shares during the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Insider Buying and Selling at STERIS

In related news, VP Julia Madsen sold 5,008 shares of the firm’s stock in a transaction dated Friday, November 21st. The shares were sold at an average price of $262.00, for a total transaction of $1,312,096.00. Following the completion of the sale, the vice president directly owned 10,710 shares in the company, valued at approximately $2,806,020. This trade represents a 31.86% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP John Adam Zangerle sold 15,000 shares of the stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $265.14, for a total transaction of $3,977,100.00. Following the completion of the sale, the vice president directly owned 33,669 shares of the company’s stock, valued at approximately $8,926,998.66. This trade represents a 30.82% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 25,044 shares of company stock valued at $6,586,218. 1.07% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a research note on Friday. Seven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $273.50.

STERIS Stock Up 1.5%

NYSE:STE opened at $260.61 on Tuesday. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.37 and a quick ratio of 1.63. The company’s fifty day moving average price is $257.99 and its 200-day moving average price is $246.01. STERIS plc has a 1-year low of $204.28 and a 1-year high of $268.60. The firm has a market capitalization of $25.58 billion, a P/E ratio of 37.44 and a beta of 1.03.

STERIS (NYSE:STE) last posted its earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.38 by $0.09. The company had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. STERIS had a net margin of 12.07% and a return on equity of 14.43%. During the same period in the previous year, the firm posted $2.14 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. As a group, equities research analysts anticipate that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, December 18th. Investors of record on Tuesday, November 18th were given a dividend of $0.63 per share. This represents a $2.52 annualized dividend and a yield of 1.0%. The ex-dividend date was Tuesday, November 18th. STERIS’s dividend payout ratio (DPR) is currently 36.21%.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.